Search for: "Burrill v. United States" Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Aug 2021, 4:22 am by SHG
On the surface, this would appear to be a flagrant violation of the Equal Protection Clause if it happened in the United States. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]